SCHEMBL3479666

SCHEMBL3479666

CN1CCN(c2ccccc2)c2ccc(-n3cccn3)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
DRD4 P21917 1/20 0.40
SCN9A Q15858 2/20 0.40
AVPR2 P30518 1/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
NOTUM Q6P988 1/20 0.36
SCN5A Q14524 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36
CHRNA9 Q9UGM1 1/20 0.36
CRHR1 P34998 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAT2A P31153 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235491 0.92 SCN9A (0.41) SCN9AHTR2ANOTUMSCN5ACHRNA7
SCHEMBL3236117 0.91 NOTUM (0.50) DRD2DRD3DRD4SCN9AAVPR2
SCHEMBL3479528 0.89 HTR3A (0.45) DRD2SCN9AAVPR2HTR1AHTR2A
SCHEMBL3479774 0.87 SCN9A (0.38) SCN9AAVPR2HTR2ANOTUMSCN5A
SCHEMBL3479720 0.86 CCNA2 (0.38) SCN9AAVPR2NOTUMSCN5ACHRNA7
SCHEMBL3479558 0.82 SCN9A (0.39) DRD3SCN9AHTR1DHTR1BCHRNA7
SCHEMBL3479777 0.80 ADRA2C (0.51) DRD2DRD3SCN9AHTR1AHTR1B
SCHEMBL3479741 0.80 HRH3 (0.42) DRD3SCN9ALMNAALDH1A1POLB
SCHEMBL3479641 0.77 HRH4 (0.44) DRD3SCN9A
SCHEMBL3235658 0.76 SLC6A2 (0.43) SCN9AHTR1AKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D DRD2 5/4885DRD3 12/4885DRD4 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.